Galectin Therapeutics Inc (GALT) — Financial Flexibility Index
Galectin Therapeutics Inc (GALT) has a Financial Flexibility Index of -0.03x as of March 2026. Free cash flow of $-3.87 Million (operating CF $-3.87 Million minus capex $0.00) represents 0% of total liabilities ($146.00 Million). Check GALT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Galectin Therapeutics Inc Financial Flexibility Index (2000–2025)
Historical Financial Flexibility Index trend for Galectin Therapeutics Inc across 26 annual periods. For the full cash flow conversion analysis, see GALT cash flow conversion.
Annual Financial Flexibility Index for Galectin Therapeutics Inc (2000–2025)
Year-by-year free cash flow to debt coverage for Galectin Therapeutics Inc. Explore Galectin Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.16x | $-23.88 Million | $-23.88 Million | $145.73 Million | ▲ +52.7% |
| 2024 | -0.35x | $-41.77 Million | $-41.77 Million | $120.56 Million | ▲ +7.1% |
| 2023 | -0.37x | $-32.97 Million | $-32.97 Million | $88.44 Million | ▲ +35.8% |
| 2022 | -0.58x | $-31.06 Million | $-31.06 Million | $53.48 Million | ▲ +6.3% |
| 2021 | -0.62x | $-24.31 Million | $-24.31 Million | $39.21 Million | ▲ +83.7% |
| 2020 | -3.81x | $-20.60 Million | $-20.60 Million | $5.41 Million | ▼ -0.9% |
| 2019 | -3.78x | $-10.85 Million | $-10.85 Million | $2.87 Million | ▲ +21.8% |
| 2018 | -4.83x | $-10.18 Million | $-10.18 Million | $2.11 Million | ▲ +9.8% |
| 2017 | -5.35x | $-15.89 Million | $-15.89 Million | $2.97 Million | ▼ -23.3% |
| 2016 | -4.34x | $-16.41 Million | $-16.41 Million | $3.78 Million | ▲ +65.2% |
| 2015 | -12.49x | $-16.98 Million | $-16.98 Million | $1.36 Million | ▼ -71.1% |
| 2014 | -7.30x | $-12.43 Million | $-12.43 Million | $1.70 Million | ▼ -142.5% |
| 2013 | -3.01x | $-7.48 Million | $-7.48 Million | $2.49 Million | ▲ +34.0% |
| 2012 | -4.56x | $-7.50 Million | $-7.50 Million | $1.64 Million | ▼ -78.1% |
| 2011 | -2.56x | $-5.67 Million | $-5.68 Million | $2.21 Million | ▼ -559.8% |
| 2010 | -0.39x | $-3.10 Million | $-3.10 Million | $7.99 Million | ▲ +51.1% |
| 2009 | -0.79x | $-3.89 Million | $-3.89 Million | $4.90 Million | ▲ +80.1% |
| 2008 | -3.98x | $-4.66 Million | $-4.67 Million | $1.17 Million | ▼ -243.8% |
| 2007 | -1.16x | $-5.44 Million | $-5.48 Million | $4.71 Million | ▼ -10.9% |
| 2006 | -1.04x | $-6.66 Million | $-6.76 Million | $6.38 Million | ▲ +76.4% |
| 2005 | -4.42x | $-6.11 Million | $-6.13 Million | $1.38 Million | ▲ +29.5% |
| 2004 | -6.28x | $-6.31 Million | $-6.33 Million | $1.00 Million | ▲ +42.3% |
| 2003 | -10.88x | $-4.11 Million | $-4.15 Million | $377.91K | ▼ -153.8% |
| 2002 | -4.29x | $-2.86 Million | $-2.98 Million | $666.79K | ▼ -45.0% |
| 2001 | -2.96x | $-1.63 Million | $-1.80 Million | $550.70K | ▼ -565.2% |
| 2000 | -0.44x | $-80.00K | $-90.00K | $180.00K | — |